Last Updated: Thursday, September 10, 2015, 08:04
"Decisions are being made to either close or divest some of our manufacturing facilities," a Sun Pharma spokesman said in an emailed statement.
Last Updated: Wednesday, August 5, 2015, 15:15
However, the fees for facility inspection of foreign companies have been reduced, which may encourage more firms to opt for audit of their facilities by the regulator.
Last Updated: Saturday, July 25, 2015, 15:28
The New York City Health Department has asked city residents to stop using certain Ayurvedic medications made by a leading Indian pharma company, saying the products contain "elevated" levels of lead and mercury making them unsafe for "human consumption".
Last Updated: Wednesday, July 1, 2015, 17:09
Recently, the drug firm had said that it intends to invest up to Rs 900 crore this fiscal on various activities including capacity expansion, clinical trials and product filings.
Last Updated: Wednesday, April 8, 2015, 17:50
In a regulatory filing with the National Stock Exchange, the company said that under the terms of the agreed settlement, "there is no admission of liability".
Last Updated: Monday, April 6, 2015, 18:01
Mankind Pharma is investing around Rs 100 crore to set up an active pharmaceutical ingredients (API) facility in Rajasthan, which is expected to go on stream by the end of the year.
Last Updated: Monday, March 30, 2015, 18:17
Catamaran helps employers and health insurers obtain prescription drugs at a lower rate from pharmaceutical groups and pharmacists, and is known as a pharmacy-benefit management company.
Last Updated: Monday, March 16, 2015, 15:24
Lupin had earlier acquired 60 per cent stake in the South African (SA) firm in September, 2008.
Last Updated: Tuesday, March 3, 2015, 15:50
The DC Federal Court in the US has upheld the decision of the USFDA for rescinding tentative approvals given to it for generic digestive disorder drug Nexium and antiviral Valcyte.
Last Updated: Tuesday, March 3, 2015, 09:53
The business includes two manufacturing sites in Tasmania and Victoria, and consists of poppy-derived opiate raw materials mainly used to make analgesics for pain treatment.
Last Updated: Monday, February 23, 2015, 15:42
The company said it has received the final approval for its product, a generic version of Allergan Inc's Lumigan Ophthalmic Solution, from the US Food and Drug Administration (USFDA).
Last Updated: Sunday, February 15, 2015, 11:00
Pain, inflammation and oncology are the therapeutic areas currently the drug maker is working on, said Glenn Saldanha, Chairman & Managing Director, Glenmark Pharmaceuticals Ltd.
more videos >>
